118 related articles for article (PubMed ID: 236372)
1. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
Lalka D; Jusko WJ; Bardos TJ
J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
[No Abstract] [Full Text] [Related]
2. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems. I. Colorimetric estimation and stability in physiological media.
Lalka D; Bardos TJ
J Pharm Sci; 1973 Aug; 62(8):1294-8. PubMed ID: 4737580
[No Abstract] [Full Text] [Related]
3. [Kinetics of accumulation and elimination of 14C-dipine, an antineoplastic drug].
Korolev GK; Kurasova VG; Kurchatova VV
Farmakol Toksikol; 1978; 41(4):473-80. PubMed ID: 668875
[TBL] [Abstract][Full Text] [Related]
4. [Activation of ifosfamide in man and animal].
Brock N; Hoefer-Janker H; Hohorst HJ; Scheef W; Schneider B; Wolf HC
Arzneimittelforschung; 1973 Jan; 23(1):1-14. PubMed ID: 4353374
[No Abstract] [Full Text] [Related]
5. [Study of the pharmacokinetics of phosphemide in rats with the use of physico-chemical methods].
Safonova TS; Presnova ZhF; Linberg LF; Chernov VA; Kuriatov NS
Farmakol Toksikol; 1975; 38(4):491-4. PubMed ID: 1213145
[TBL] [Abstract][Full Text] [Related]
6. Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.
Bachur NR; Collins JM; Kelley JA; Van Echo DA; Kaplan RS; Whitacre M
Clin Pharmacol Ther; 1982 May; 31(5):650-5. PubMed ID: 7075113
[TBL] [Abstract][Full Text] [Related]
7. The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles.
Feun LG; Savaraj N; Lu K; Guo Z; Raulston LG; Benjamin RS; Fields WS; Loo TL
J Neurooncol; 1983; 1(3):219-24. PubMed ID: 6678971
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of diaziquone after three different dosage regimens.
Bjornsson TD; Schold SC; Friedman HS; Schneider D; Falletta JM
Cancer Treat Rep; 1985 Dec; 69(12):1383-5. PubMed ID: 4075314
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
Wampler GL; Kuperminc M; Regelson W
Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
[TBL] [Abstract][Full Text] [Related]
10. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
[TBL] [Abstract][Full Text] [Related]
11. A new metabolic reaction of diaziridines by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1982 May; 106(2):526-32. PubMed ID: 7104007
[No Abstract] [Full Text] [Related]
12. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
[No Abstract] [Full Text] [Related]
13. The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies.
Egorin MJ; Bellis EH; Salcman M; Collins JM; Spiegel JF; Bachur NR
J Neurosurg; 1984 May; 60(5):1005-13. PubMed ID: 6716135
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity and fragmentation of aziridines in microsomes.
Hata Y; Watanabe M; Shiratori O; Takase S
Biochem Biophys Res Commun; 1978 Feb; 80(4):911-6. PubMed ID: 637875
[No Abstract] [Full Text] [Related]
15. Structure activity relationships in a series of anti-neoplastic dinitrophenyl aziridines--protein binding studies.
Hickman JA
Biochem Pharmacol; 1974 Oct; 23(20):2833-8. PubMed ID: 4473986
[No Abstract] [Full Text] [Related]
16. CB 1954 revisited. I. Disposition kinetics and metabolism.
Workman P; White RA; Talbot K
Cancer Chemother Pharmacol; 1986; 16(1):1-8. PubMed ID: 3940216
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1976 Nov; 25(22):2475-8. PubMed ID: 985569
[No Abstract] [Full Text] [Related]
18. [Study of the decomposition of alkylating mutagens of the ethyleneimine series in human lymphocyte cultures].
Kirichenko OP; Chebotarev AN; Lakovenko KN
Biull Eksp Biol Med; 1976 May; 81(5):552-3. PubMed ID: 820384
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of vincristine and alkylating agent No. 864 on rat leukemia in relation to the distribution of drugs and leukemic cells.
Aoshima M; Sakurai Y
Gan; 1973 Oct; 64(5):417-25. PubMed ID: 4358729
[No Abstract] [Full Text] [Related]
20. DNA modifications by potential antitumour bisaziridinylquinones.
de Mol NJ; Lusthof KJ; Decuyper J
Biochem Pharmacol; 1988 May; 37(9):1837-8. PubMed ID: 3288218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
